Skip to main content

🚀 Special Offer🚀Get 25% off on your bioreagent online order (except Micelles and Nanodiscs), with the code: PROTEOSHOP25

📢 New ! Accelerate your Antibody Development with Ready-to-use Stable Cell Pools

Explore Now

Filter

Therapeutic NANOBODY® proteins

Therapeutic NANOBODY® proteins are single-domain antibody fragments derived from heavy-chain-only antibodies found in camelids. Their small size (~15 kDa), high solubility, and exceptional stability under a wide range of conditions… Read more
7 Products
Show items

Contact us

Send us a message from the contact form below

    What Are Therapeutic NANOBODY® Proteins?

    Therapeutic NANOBODY® proteins are single-domain antibody fragments derived from heavy-chain-only antibodies found in camelids. Their small size (~15 kDa), high solubility, and exceptional stability under a wide range of conditions make them powerful tools in therapeutic development. Unlike conventional monoclonal antibodies, NANOBODY® proteins can access hidden or sterically restricted epitopes, allowing them to neutralize targets with higher precision.

    Activity and Mechanism of Action

    NANOBODY® proteins exhibit high affinity and specificity for their targets, ranging from extracellular receptors to intracellular proteins. Their mechanisms include:
    • Blocking ligand-receptor interactions
    • Neutralizing toxins and viral particles
    • Modulating enzyme activity
    • Acting as carriers for drug delivery or diagnostics
    Due to their robustness, NANOBODY® molecules are ideal for inhalable formulations, topical applications, and even intracellular delivery.

    Applications in Life Science Research and Therapy

    Therapeutic NANOBODY® proteins are transforming life science research and clinical development:
    • Oncology: Blocking immune checkpoints (e.g., PD-L1) and targeting tumor-specific antigens
    • Infectious diseases: Neutralizing viral proteins, including SARS-CoV-2 spike protein
    • Neurodegenerative diseases: Crossing the blood-brain barrier for targeted delivery
    • Diagnostics: Imaging agents due to rapid clearance and high tissue penetration

    How to Choose the Right NANOBODY® Protein for Therapeutic Development

    Choosing the right NANOBODY® VHH depends on your project needs. Here are some considerations:
    • Define the target (e.g., membrane protein, toxin, intracellular protein)
    • Determine the required affinity and epitope specificity
    • Consider the final format: naked nanobody, Fc-fusion, or drug conjugate
    • Assess delivery route and formulation constraints (e.g., systemic vs. local)
    • Validate stability, aggregation profile, and manufacturability
    ProteoGenix offers biosimilar NANOBODY® proteins tailored for therapeutic, diagnostic, and research applications. Our expertise ensures seamless integration into your therapeutic development pipeline.

    Cart (0 Items)

    Your cart is currently empty.

    View Products